Antibiotice Iasi Posts 0.5% Higher Sales Revenue And Flat Profit In 2014

02.13.2015 By Ecaterina Craciun

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) on Friday said its sales revenue inched up 0.5% on the year in 2014, to 318.9 million lei (EUR71.8 million), while its profit stagnated at nearly RON31.3 million (EUR7 million), according to the company’s preliminary report.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

 
Keywords:
ANTIBIOTICE
, SALES REVENUE
,